Staley Capital Advisers Inc Johnson & Johnson Transaction History

Staley Capital Advisers Inc

$2.2 Billion
Q3 2024

A detailed history of Staley Capital Advisers Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Staley Capital Advisers Inc holds 301,662 shares of JNJ stock, worth $43.9 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares

301,662

Previous 301,178 0.16%

Holding current value

$43.9 Million

Previous $44 Million 11.06%

% of portfolio

2.22%

Previous 2.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$145.48 - $167.38 $70,412 - $81,011	484 Added 0.16%	301,662 $48.9 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $1.52 Million - $1.66 Million	10,519 Added 3.62%	301,178 $44 Million
Q1 2024 May 06, 2024	BUY	$155.22 - $162.74 $311,836 - $326,944	2,009 Added 0.7%	290,659 $46 Million
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $1.14 Million - $1.25 Million	7,855 Added 2.8%	288,650 $45.2 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $1.01 Million - $1.13 Million	6,454 Added 2.35%	280,795 $43.7 Million
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $531,581 - $572,082	3,444 Added 1.27%	274,341 $45.4 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $3.36 Million - $4.01 Million	22,265 Added 8.96%	270,897 $42 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $145,461 - $163,249	-908 Reduced 0.36%	248,632 $43.9 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $368,316 - $409,844	2,283 Added 0.92%	249,540 $40.8 Million
Q2 2022 Aug 05, 2022	SELL	$168.19 - $186.01 $757,864 - $838,161	-4,506 Reduced 1.79%	247,257 $43.9 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $237,209 - $269,385	1,500 Added 0.6%	251,763 $44.6 Million
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $499,443 - $554,151	-3,203 Reduced 1.26%	250,263 $42.8 Million
Q3 2021 Nov 05, 2021	SELL	$161.5 - $179.47 $714,960 - $794,513	-4,427 Reduced 1.72%	253,466 $40.9 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $126,627 - $135,829	794 Added 0.31%	257,893 $42.5 Million
Q1 2021 May 06, 2021	BUY	$153.07 - $170.48 $2.56 Million - $2.85 Million	16,739 Added 6.96%	257,099 $42.3 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $1.29 Million - $1.48 Million	9,412 Added 4.08%	240,360 $37.8 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $902,924 - $989,434	-6,432 Reduced 2.71%	230,948 $34.4 Million
Q2 2020 Aug 07, 2020	SELL	$128.81 - $155.51 $194,503 - $234,820	-1,510 Reduced 0.63%	237,380 $33.4 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $163,042 - $225,903	1,467 Added 0.62%	238,890 $31.3 Million
Q4 2019 Feb 04, 2020	BUY	$127.5 - $146.44 $870,187 - $999,453	6,825 Added 2.96%	237,423 $34.6 Million
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $419,823 - $470,056	3,307 Added 1.45%	230,598 $29.8 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $35,279 - $38,800	-269 Reduced 0.12%	227,291 $31.7 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $135,903 - $151,112	1,081 Added 0.48%	227,560 $31.8 Million
Q4 2018 Feb 05, 2019	SELL	$122.84 - $147.84 $45,327 - $54,552	-369 Reduced 0.16%	226,479 $29.2 Million
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $318,661 - $374,488	2,621 Added 1.17%	226,848 $31.3 Million
Q2 2018 Aug 08, 2018	BUY	$119.4 - $131.76 $2.44 Million - $2.7 Million	20,461 Added 10.04%	224,227 $27.2 Million
Q1 2018 May 09, 2018	BUY	$125.1 - $148.14 $727,206 - $861,137	5,813 Added 2.94%	203,766 $26.1 Million
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $6,429 - $7,037	-49 Reduced 0.02%	197,953 $27.7 Million
Q3 2017 Nov 09, 2017	SELL	$129.47 - $135.38 $543,644 - $568,460	-4,199 Reduced 2.08%	198,002 $25.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	202,201	202,201 $26.7 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.

Account

Staley Capital Advisers Inc Johnson & Johnson Transaction History